In accordance with the prominent role of FGF-2 in vivo is the finding of enhanced FGF-2 levels in multiple sclerosis lesions, which could originate from activated astrocytes and microglia and help to repopulate the tissue with OPCs (Clemente et al., 2011). This evidence concerns the gene FGF2 and multiple sclerosis.